Chemours (CC) PT Lowered to $54 at UBS

Go back to Chemours (CC) PT Lowered to $54 at UBS

Chemours (CC) PT Raised to $70 at BMO Capital; Remains Top Pick

May 8, 2018 9:26 AM EDT

BMO Capital raised its price target on Chemours (NYSE: CC) to $70.00 (from $68.00) while maintaining a Outperform rating.

Analyst John McNulty commented, "We continue to believe in the TiO2 story (elongated cycle, tight supply, price-value stabilization) but see room for Fluoro to exceed... More

Chemours (CC) PT Raised to $69 at Citi

May 8, 2018 6:12 AM EDT

Citi raised its price target on Chemours (NYSE: CC) to $69.00 (from $66.00) while maintaining a Buy rating.

... More